SCHEMBL17675155

SCHEMBL17675155

O=C1NC(C(=O)O)CCc2ccccc21

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.46
TSHR P16473 2/20 0.46
GAA P10253 1/20 0.46
PDPK1 O15530 1/20 0.46
PARP1 P09874 1/20 0.46
PARP10 Q53GL7 1/20 0.46
PARP11 Q9NR21 1/20 0.46
MME P08473 10/20 0.44
ACE P12821 5/20 0.43
KDM4E B2RXH2 2/20 0.41
ALDH1A1 P00352 2/20 0.41
LMNA P02545 1/20 0.41
HPGD P15428 1/20 0.41
CA12 O43570 1/20 0.41
CA9 Q16790 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
CES1 P23141 1/20 0.40
HSD17B10 Q99714 1/20 0.39
TDP1 Q9NUW8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1252255 0.83 GAA (0.62) MAPTTSHRGAAPDPK1PARP1
SCHEMBL1252254 0.83 GAA (0.62) MAPTTSHRGAAPDPK1PARP1
SCHEMBL2080900 0.83 GAA (0.62) MAPTTSHRGAAPDPK1PARP1
SCHEMBL17648067 0.82 TSHR (0.46) MAPTTSHRPDPK1PARP1PARP10
SCHEMBL7425901 0.79 KDM4E (0.47) MAPTTSHRKDM4EALDH1A1LMNA
SCHEMBL1531662 0.78 GAA (0.69) MAPTGAAMMEACEALDH1A1
SCHEMBL29831598 0.78 GAA (0.69) MAPTGAAMMEACEALDH1A1
SCHEMBL1150614 0.78 GAA (0.69) MAPTGAAMMEACEALDH1A1
SCHEMBL444953 0.78 GAA (0.69) MAPTGAAMMEACEALDH1A1
SCHEMBL22800232 0.78 MME (0.45) MAPTTSHRGAAPDPK1PARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3203840-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2017-08-16 EP disclosed
WO-2016057572-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR MILLER MARK THOMAS (US) 2016-04-14 WO disclosed